Vimarsana
Biggest News Aggregation in the World

David Schull News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from David Schull. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In David Schull Today - Breaking & Trending Today

Clene Provides Update On Its NIH-Funded Expanded Access Program For CNM-Au8® In ALS (ACT-EAP) - Vimarsana News

Clene Provides Update On Its NIH-Funded Expanded Access Program For CNM-Au8® In ALS (ACT-EAP)

Source: menafn.com
Spectral AI Announces Purchases of Over 100,000 Shares by Insiders - Vimarsana News

Spectral AI Announces Purchases of Over 100,000 Shares by Insiders

DALLAS, May 17, 2024 -- Spectral AI, Inc. , an artificial intelligence company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, today announced that...

Spectral AI Awarded Quality Achievement Award from the Texas Manufacturer Assistance Center - Vimarsana News

Spectral AI Awarded Quality Achievement Award from the Texas Manufacturer Assistance Center

DALLAS, April 30, 2024 -- Spectral AI, Inc. , an artificial intelligence company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, today announced...

Spectral AI Names Erich Spangenberg CEO of its IP Focused Subsidiary and Explores Potential Spin-Off of that Subsidiary - Vimarsana News

Spectral AI Names Erich Spangenberg CEO of its IP Focused Subsidiary and Explores Potential Spin-Off of that Subsidiary

Spangenberg brings significant IP monetization experience and the potential to unlock additional value for Spectral AI shareholdersDALLAS, April 24, 2024 -- Spectral AI, Inc. , an artificial...

Catalyst Pharmaceuticals to Report First Quarter 2024 Financial Results on May 8, 2024 - Vimarsana News

Catalyst Pharmaceuticals to Report First Quarter 2024 Financial Results on May 8, 2024

22.04.2024 - The Company will Host a Conference Call and Webcast on Thursday, May 9, 2024, at 8:30 AM ETCORAL GABLES, Fla., April 22, 2024 (GLOBE NEWSWIRE) - Catalyst Pharmaceuticals, Inc. (“Catalyst” or “Company”) (Nasdaq: CPRX), a commercial-stage ...